Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |